ArticleHuman vaccines & immunotherapeutics2023

Complete pathological remission and tertiary lymphoid structures are associated with the efficacy of resectable NSCLC receiving neoadjuvant chemoimmunotherapy: A double-center retrospective study.

Ying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.